|
FY2018
12 months to Mar 31, 2018
|
FY2017
12 months to Mar 31, 2017
|
FY2016
12 months to Mar 31, 2016
|
FY2015
12 months to Mar 31, 2015
|
FY2014
12 months to Mar 31, 2014
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Interest expense paid in kind as convertible note debt | |||||
| Impairment of software development costs | |||||
| Loss on fixed asset disposal | |||||
| Deferred tax liability | |||||
| Noncash income tax benefit | |||||
| Unrealized currency translation gains | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued payroll and related liabilities | |||||
| Accrued restructuring costs | |||||
| Impairment of capitalized software | |||||
| Other accrued liabilities and long-term liabilities | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Investing activities | |||||
| Minority shareholder payment | |||||
| Purchase of business acquired, net of cash | |||||
| Purchase of property and equipment | |||||
| Capitalized software development costs, net | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Proceeds from sale of preferred stock with warrants, net of issuance costs | |||||
| Proceeds from issuance of stock, net of issuance costs | |||||
| Credit facility borrowing | |||||
| Credit facility payment | |||||
| Net employee withholding taxes paid in connection to issuance of restricted stock | |||||
| Issuance of stock under employee stock purchase plan | |||||
| Repayment of loan | |||||
| Fees paid in connection with conversion of preferred stock to common stock | |||||
| Proceeds from exercise of stock options | |||||
| Issuance of convertible note, net of debt issuance costs | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the period | |||||
| Cash and cash equivalents at end of the period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for taxes | |||||
| Beneficial conversion feature for convertible redeemable preferred stock | |||||
| Accretion of preferred series stock to redemption value | |||||
| Conversion of Series F stock into common stock | |||||
| Assumption of debt in connection with business combination | |||||
| Stock issued | |||||
| Issued for Business Combination | |||||
| Issued for Interest on Convertible Notes | |||||
| Issuance of Shares in Business Combination | |||||
| Stock Issued Upon Conversion of Convertible Note | |||||
| Stock Issued in Connection with Loan Guarantee Extension | |||||
| Stock Issued in Connection with Interest on Loan Guaranty | |||||
| Stock Issued in Connection with Interest on Convertible Note | |||||
| Issuance of Common Stock for a Legal Settlement | |||||
| Gain from convertible note extinguishment | |||||
Loading...